#GivingTuesday, November 29th, is a day dedicated to being generous. In direct contrast to #BlackFriday and #CyberMonday, days that are set aside for consumerism, it is an opportunity for coming together as a community to make an impact on the lives of GIST patients.
#GivingTuesday helps to kick off the Life Raft Group’s Holiday Campaign
We’ve done a tremendous amount in the 16 years the Life Raft Group has been around. We’ve built a sophisticated and unparalleled patient registry that has provided data that has saved countless lives. We launched a virtual tumor board to fill the needs of patients far removed from GIST centers of excellence. Our tissue bank contributes to ongoing GIST research, and our Expert Training course, GDOLs and webcasts continue to empower patients with education. Our biennial Life Fest conferences bring together leading GIST experts and a supportive community in which to share the latest in research as well as support for one another. Our efforts have resulted in empowered and educated patients who live longer.
We have also built a family – a family who supports each other through this journey called GIST.
But it is not enough. VP Biden’s Cancer Moonshot initiative implores us to step up our efforts, and although we have already begun, the next phase of the Life Raft Group is crucial to our own “moonshot” goal – to double patient survival.
We need you to make it happen, so that patients, caregivers and families can be granted additional time to make memories and to enjoy life to the fullest.
Please consider “doubling” your donation this year, so that we may double patient survival by continuing the work we have always done, and by implementing the exciting new research tools we have been working on.
On this #GivingTuesday and until December 31st, please consider donating to the LRG.
Click image above to watch video
Throughout the holiday campaign, you will hear from patients and caregivers who want to realize their dreams. GISTer MaKayla Evans launches the campaign with her story.
Help us realize ours to double patient survival, and to help patients not only survive, but thrive.
